<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Acta Otorhinolaryngol Ital</journal-id>
      <journal-id journal-id-type="publisher-id">Pacini</journal-id>
      <journal-title-group>
        <journal-title>Acta Otorhinolaryngologica Italica</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0392-100X</issn>
      <issn pub-type="epub">1827-675X</issn>
      <publisher>
        <publisher-name>Pacini Editore SpA</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21253289</article-id>
      <article-id pub-id-type="pmc">3008148</article-id>
      <article-id pub-id-type="publisher-id">Pacini</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">
Case reports on two patients with episodic vertigo,
fluctuating hearing loss and migraine responding
to prophylactic drugs for migraine.
Meni&#xE8;re&#x2019;s disease or migraine-associated vertigo?
				</article-title>
        <trans-title-group xml:lang="it">
          <trans-title>Caso clinico di due pazienti con episodi di vertigine recidivante, ipoacusia
fluttuante ed emicrania con buona responsivit&#xE0; alla terapia profilattica
per l&#x2019;emicrania. Malattia di Meni&#xE8;re o vertigine emicranica?</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>TEGGI</surname>
            <given-names>R.</given-names>
          </name>
          <xref ref-type="corresp" rid="COR1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>FABIANO</surname>
            <given-names>B.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>RECANATI</surname>
            <given-names>P.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>LIMARDO</surname>
            <given-names>P.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>BUSSI</surname>
            <given-names>M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>ENT Department, "San Raffaele" Hospital, "Vita-Salute" University, Milan, Italy</aff>
      <author-notes>
        <corresp id="COR1">
Address for correspondence: Dr. R. Teggi, Divisione di Otorinolaringoiatria,
Ospedale "San Raffaele", via Olgettina 60, 20132 Milano,
Italy. Fax: +39 02 26433508. E-mail: <email xlink:href="teggi.roberto@hsr.it">teggi.roberto@hsr.it</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2010</year>
      </pub-date>
      <volume>30</volume>
      <issue>4</issue>
      <elocation-id>217</elocation-id>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>7</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>09</day>
          <month>1</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Copyright by Societ&#xE0; Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link></license-p>
        </license>
      </permissions>
      <abstract>
        <title>SUMMARY</title>
        <p>Recent reports have focused on a possible association between migraine and Meni&#xE8;re&#x2019;s disease; patients suffering from Meni&#xE8;re&#x2019;s disease
present a higher rate of migraine. In some cases, the clinical features of migraine-associated vertigo may mimic the presentation of
Meni&#xE8;re&#x2019;s disease. The present report focuses on two cases of females with recurrent episodes of rotational vertigo, fluctuating hearing
loss and tinnitus lasting from a few minutes to several hours; both cases also presented migrainous attacks. As a result of repeated cochleovestibular
attacks, both patients presented a permanent low frequency sensorineural hearing loss. Preventive therapies for Meni&#xE8;re&#x2019;s disease
did not reduce vertigo attacks, while topiramate and acetylsalicylic acid treatment resulted in a significant reduction of both migraine
and vertigo. Both the diagnosis of Meni&#xE8;re&#x2019;s disease and of migraine-associated vertigo rely on clinical history and both disorders lack a
specific diagnostic test. In the early stages, differential diagnosis between Meni&#xE8;re&#x2019;s disease and migraine-associated vertigo is often very
difficult; previous investigations focused on the possibility that subjects with migraine may experience all symptoms of Meni&#xE8;re&#x2019;s disease,
including sensorineural fluctuating hearing loss. In conclusion, a trial with prophylactic drug treatment for migraine might be suggested in
patients with clear symptoms of migraine and recurrent cochleovestibular disorders.</p>
      </abstract>
      <trans-abstract xml:lang="it">
        <title>RIASSUNTO</title>
        <p>Recentemente la letteratura scientifica ha posto l&#x2019;attenzione sulla possibile associazione tra emicrania e malattia di Meni&#xE8;re; pazienti
affetti da malattia di Meni&#xE8;re presentano una pi&#xF9; alta incidenza di emicrania. In alcuni casi, le manifestazioni cliniche della vertigine
emicranica possono mimare la presentazione della malattia di Meni&#xE8;re. Presentiamo due casi di pazienti donne con episodi ricorrenti di
vertigine rotazionale, ipoacusia fluttuante e acufene della durata variabile da minuti ad ore; entrambi i casi presentavano attacchi di emicrania.
Come risultato di reiterati attacchi cocleovestibolari, i pazienti presentavano ipoacusia neurosensoriale permanente per le basse
frequenze. La terapia di prevenzione per la malattia di Meni&#xE8;re non riduceva gli attacchi vertiginosi, mentre la somministrazione di topiramato
e acido acetilsalicilico determinava una drastica riduzione sia dell&#x2019;emicrania sia della vertigine. Entrambe le diagnosi di malattia
di Meni&#xE8;re e vertigine emicranica si basano sulla storia clinica e non posseggono test diagnostici specifici. Negli stadi precoci, la diagnosi
di differenziale tra malattia di Meni&#xE8;re e vertigine emicranica &#xE8; spesso piuttosto difficoltosa; lavori precedenti sottolineano la possibilit&#xE0;
che soggetti affetti da emicrania possono manifestare tutti i sintomi di malattia di Meni&#xE8;re, inclusa l&#x2019;ipoacusia neurosensoriale fluttuante.
In conclusione, una terapia farmacologica profilattica per emicrania potrebbe essere consigliata nei soggetti con franca sintomatologia
emicranica associata a disordini cocleovestibolari ricorrenti.</p>
      </trans-abstract>
      <kwd-group>
        <title>KEY WORDS</title>
        <kwd>Vertigo</kwd>
        <kwd>Meni&#xE8;re's disease</kwd>
        <kwd>Migraine</kwd>
        <kwd>Migraine-associated vertigo</kwd>
        <kwd>Sensorineural hearing loss</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S1">
      <title>Introduction</title>
      <p>Meni&#xE8;re&#x2019;s disease (MD) is an inner ear disorder characterized
by recurrent episodes of rotational vertigo, most
typically associated with fluctuating progressive hearing
loss, typically on low frequencies in early stages, fullness
and tinnitus. Raised endolymphatic pressure (hydrops) is
commonly accepted as the causal condition <xref ref-type="bibr" rid="R01"><sup>1</sup></xref> <xref ref-type="bibr" rid="R02"><sup>2</sup></xref>.</p>
      <p>Criteria used to define MD are: the presence of at least
two episodes of vertigo of at least 20 minutes&#x2019; duration,
audiometrically confirmed sensorineural hearing loss on
at least one occasion, tinnitus or aural fullness during
episodes and exclusion of other possible causes of vertigo
<xref ref-type="bibr" rid="R03"><sup>3</sup></xref>. Prosper Meni&#xE8;re himself observed the association
between MD and migraine <xref ref-type="bibr" rid="R04"><sup>4</sup></xref>.</p>
      <p>Various studies have focused on the higher prevalence
of migraine in MD patients, variously reported at between
43% and 56%, while in the normal population it
is 10% <xref ref-type="bibr" rid="R05"><sup>5</sup></xref> <xref ref-type="bibr" rid="R06"><sup>6</sup></xref>.</p>
      <p>On the other hand, there is a higher prevalence of MD
in a population screened for migraine compared to the
incidence in the general population <xref ref-type="bibr" rid="R07"><sup>7</sup></xref>. Epidemiology of
both MD and migraine-associated vertigo (MAV) may
underline a possible pathogenetic link between the 2 diseases
<xref ref-type="bibr" rid="R08"><sup>8</sup></xref> <xref ref-type="bibr" rid="R09"><sup>9</sup></xref>.</p>
      <p>Migraine is an increasingly recognized cause of recurrent
vestibular symptoms; features of MAV include both true
rotational vertigo and subjective vertigo lasting from a
few minutes to days. During attack-free periods, several
studies have documented vestibular anomalies in 30-55%
of subjects <xref ref-type="bibr" rid="R10"><sup>10</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R12"><sup>12</sup></xref>.</p>
      <p>According to Neuhauser et al. <xref ref-type="bibr" rid="R13"><sup>13</sup></xref>, diagnostic criteria for
definite MAV are:</p>
      <list list-type="bullet">
        <list-item>
          <p>episodic vestibular symptoms of at least moderate severity (rotational vertigo, other illusory self or object motion, positional vertigo, head motion intolerance);</p>
        </list-item>
        <list-item>
          <p>at least two of the following migrainous symptoms during at least two vertiginous attacks: (a) migrainous headache, (b) photophobia, (c) phonophobia, (d) visual or other aurae;</p>
        </list-item>
        <list-item>
          <p>attacks of migraine (independently of episodes of vertigo) according to International Headache Society (IHS) criteria;</p>
        </list-item>
        <list-item>
          <p>some central and/or peripheral vestibular abnormalitites found in vertigo-free periods.</p>
        </list-item>
      </list>
      <p>MAV is the main disorder capable of mimicking MD in its
early stages. There is clinical evidence that migraine can
damage the inner ear, causing permanent hearing loss or
impairment of vestibular function <xref ref-type="bibr" rid="R14"><sup>14</sup></xref> <xref ref-type="bibr" rid="R15"><sup>15</sup></xref>. Some authors have
hypothesized that MD may develop in an ear previously
damaged by vasospasm induced by migrainous mechanisms
<xref ref-type="bibr" rid="R16"><sup>16</sup></xref>.</p>
      <p>The present report refers to two migrainous patients, presenting
with repeated episodes of rotational vertigo with
permanent sensorineural hearing loss fulfilling all of the
criteria for definite MD; their response to treatment for
MD was poor whilst they showed a satisfactory response
to prophylactic drugs for migraine.</p>
    </sec>
    <sec id="S2">
      <title>Case reports</title>
      <sec id="S2a">
        <title>Case 1</title>
        <p>This patient, a 42-year-old female, was suffering from
migraine with aura according to IHS criteria. The final
diagnosis was made by a senior neurologist. The patient
reported the first attack of migraine at the age of 20 years,
which more typically occurred before menstruation, at
a frequency of 1-2/month. Her family history was positive
for migraine (mother and one of three sisters). Blood
tests showed repeated positivity for lupus-like anti-coagulants; anti-nuclear, anti-mitochondria, anti-thyroid, anticardiolipin
auto-antibodies and rheumatoid factor, on the
other hand, resulted negative. She also presented normal
C-reactive protein (CRP), erythrocyte sedimentation rate
(ESR), serum protein electrophoresis, a normal aPTT and
normal C3 and C4 levels. Central nervous system nuclear
magnetic resonance (NMR) imaging demonstrated microischaemic
lesions. High resolution computerized tomography
(CT) scan was normal. She was not receiving any
pharmaceutical treatment for migraine at the time of our
evaluation.</p>
        <p>In the previous 2 years, the patient reported recurrent episodes
of rotational vertigo (about 1/month) lasting from a
few minutes to 1-2 hours, often with a right ear fluctuating
hearing loss. Migraine and vertigo never occurred together.
As a final result, her audiometric threshold showed a
right sided low frequency sensorineural hearing loss. Pure
tone audiometry (PTA) average at 250-500 and 1000 Hz
was 35 db, while PTA average at 1-2 and 3 KHz was 15
db. She also reported the presence of tinnitus which increased
before vertigo attacks. Acoustic evoked potentials
were normal. As a result of the short duration of vertigo,
we were unable to perform an audiometric examination
during vertigo attacks. Her left ear showed a normal
threshold. Caloric tests demonstrated a right sided unilateral
weakness (26%) during caloric stimulation according
to Freyss and the Head Impulse Test was positive on
the horizontal plane with reflxation saccades towards the
left side. Vestibular evoked myogenic potentials (VEMPs)
were also recorded with an ipsilateral technique, using a
short broadband click of 0.1 msec duration, while the subject
was seated upright with her chin turned towards the
controlateral shoulder. Ongoing EMG activity was visually
monitored on an oscilloscope to ensure tension on the
sternocleidomastoid muscle greater than 65 &#xB5;V during recording.
The patient presented normal bilateral broadband
click-evoked cervical VEMPs for latency and amplitude;
on the other hand, she presented a normal 120 db SPS
(Sound Pressure Level) threshold on the unaffected side
but a 10 db threshold shift on the right side.</p>
      </sec>
      <sec id="S2b">
        <title>Case 2</title>
        <p>This patient, a 59-year-old female with a long history of
migraine which began at the age of 23 and ceased at the
age of 50, immediately after onset of menopause. She
had normal blood tests (above all rheumatologic tests),
normal central nervous system NMR imaging and normal
high resolution inner ear CT scan. Over the last year, she
reported various episodes of rotational vertigo normally
lasting for 2-3 hours with hearing loss on the left side.
She reported increased hearing loss during vertigo.
Audiometric examinations demonstrated a low frequency
sensorineural hearing loss (PTA at 250-500 and 1000
HZ 30 db while PTA at 1-2 and 3 KHz 20 db); acousticevoked
potentials presented normal latencies. Caloric tests according to Freyss demonstrated a unilateral weakness
of 40%; Head Impulse Test was positive with corrective
saccades towards the right side on the horizontal plane.</p>
        <p>Cervical VEMPs were normal for latency, amplitude and
threshold.</p>
        <p>The two patients fulfilled all AAOHNS criteria for definite
MD. In both cases, preventive therapy of MD with betahistine
24 mg twice a day, salt restriction and increased water
intake did not prevent vertigo attacks, which remained unchanged
in frequency and duration in a 6-month followup.
On the other hand, drug prophylaxis of migraine with
topiramate 100 mg a day and disaggregants (acetylsalicylic
acid 100 mg a day) produced a clear decrease in vertigo
attacks, in both patients, in a 1-year follow-up, since
patient 1 did not report any episodes of vertigo and patient
2 reported only one mild episode of about 10 min. Patient
1 also reported a reduction in migraine attacks since she
reported only one mild episode. Dietary changes, to reduce
the triggers for migraine (above all caffeine, chocolate
and red wine), were suggested to both patients.</p>
        <p>In both cases, the audiometric thresholds remained constant.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="S3">
      <title>Discussion</title>
      <p>The signs and symptoms of MAV sometimes show an
overlap with those of MD; in these cases, differential diagnosis
is often difficult. Both MD and MAV diagnoses
rely considerably on history and both disorders lack a
definite diagnostic test. It should be noted that, at present,
"hearing is the most readily measured variable and the
variable most related to the natural history of Meni&#xE8;re&#x2019;s
disease" <xref ref-type="bibr" rid="R03"><sup>3</sup></xref>.</p>
      <p>Previous investigations have focused on case studies in
which differentiating between the two disorders is a puzzling
dilemma <xref ref-type="bibr" rid="R17"><sup>17</sup></xref>.</p>
      <p>Vestibular anomalies, such as spontaneous or positional
nystagmus, failed to offer a reliable test to differentiate the
2 disorders; percentage of asymmetric caloric responses,
reported in an average of 24.5% of cases of MAV, magnitude
of unilateral weakness and rotational tests have not
been reported to be useful in discriminating between the
two disorders <xref ref-type="bibr" rid="R10"><sup>10</sup></xref> <xref ref-type="bibr" rid="R18"><sup>18</sup></xref>.</p>
      <p>Patients with MAV may experience all the symptoms of
MD, including fluctuating sensorineural hearing loss 19,
even though repeated MAV attacks very rarely produce a
permanent hearing loss <xref ref-type="bibr" rid="R20"><sup>20</sup></xref>.</p>
      <p>A fluctuating hearing loss in children has been considered,
by some authors, as a migraine equivalent <xref ref-type="bibr" rid="R21"><sup>21</sup></xref>.</p>
      <p>As also in our two patients, the majority of patients with
MAV have attacks of dizziness independently of migraine
headache; it should be noted that in our second patient,
vertigo spells began when migrainous attacks ceased <xref ref-type="bibr" rid="R22"><sup>22</sup></xref> <xref ref-type="bibr" rid="R23"><sup>23</sup></xref>.</p>
      <p>Topiramate blocks voltage-sensitive sodium channels and
voltage-activated calcium channels, inhibits glutamate release, and increases GABA levels <xref ref-type="bibr" rid="R24"><sup>24</sup></xref>. Some large studies
have demonstrated that topiramate is a safe, effective, and
well-tolerated drug for migraine prophylaxis. Above all,
few side-effects are described when topiramate is used at
doses up to 100 mg a day <xref ref-type="bibr" rid="R25"><sup>25</sup></xref> <xref ref-type="bibr" rid="R26"><sup>26</sup></xref>.</p>
      <p>These cases underline that there are some doubts concerning
the statement that "fluctuating hearing loss with vertigo
is almost always due to Meni&#xE8;re&#x2019;s disease", moreover
the pathophysiological conditions of MD and MAV are
poorly understood <xref ref-type="bibr" rid="R04"><sup>4</sup></xref> <xref ref-type="bibr" rid="R27"><sup>27</sup></xref>.</p>
      <p>Some further considerations should be added regarding
lupus anti-coagulant (LAC) positivity, white matter
micro-ischaemic lesions and migraine. LAC positivity,
as well as the presence in blood of anti-cardiolipin and
&#x3B2;<sub>2</sub>-glycoprotein I antibodies, is widely known as the antiphospholipid
syndrome; the main characteristic of the
disease is an antibody-mediated hypercoagulable state
characterized by recurrent venous and arterial thromboembolic
events. Primary antiphospholipid syndrome refers
to patients who do not have any other rheumatologic or
autoimmune conditions, whereas secondary antiphospholipid
syndrome refers to patients who also have systemic
lupus erythematosus (SLE) or other conditions. In general,
the clinical manifestations of the antiphospholipid syndrome
are similar for primary and secondary forms of the
disease <xref ref-type="bibr" rid="R28"><sup>28</sup></xref>. Antiphospholipid antibodies are found among
young, apparently healthy control subjects at a prevalence
of 1 to 5%. Cerebro-vascular events have been reported
to be positively associated with the antiphospholipid
syndrome <xref ref-type="bibr" rid="R29"><sup>29</sup></xref> <xref ref-type="bibr" rid="R30"><sup>30</sup></xref>. An association between Behcet&#x2019;s Disease
and cerebral blood flow perfusion impairment has been
demonstrated with a SPECT examination even in subjects
with normal MRI findings <xref ref-type="bibr" rid="R31"><sup>31</sup></xref>. A possible role of antiphospholipid
antibodies, in the pathogenesis of migraine, is
still under debate. No association has been found between
anti-cardiolipin autoantibodies and migraine in a paediatric
population <xref ref-type="bibr" rid="R32"><sup>32</sup></xref>, while in adults, with some exceptions <xref ref-type="bibr" rid="R33"><sup>33</sup></xref>,
the prevalence of migraine, above all with aura, has been
reported to be higher in SLE subjects than in the normal
population <xref ref-type="bibr" rid="R34"><sup>34</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R38"><sup>38</sup></xref>, and an association with antiphospholipid
syndrome has been suggested <xref ref-type="bibr" rid="R39"><sup>39</sup></xref>. The American College
of Rheumatology included headache and migraine among
the neuro-psychiatric syndromes observed in SLE <xref ref-type="bibr" rid="R40"><sup>40</sup></xref>.</p>
      <p>More frequently, in autoimmune disorders, neurologic
involvement is reported to be present in between 4 and
49%, and, moreover, in 5% of cases, it is the initial feature;
immuno-mediated disease activity may justify the
higher prevalence of migraine in autoimmune disorders
and the cerebral MRI findings <xref ref-type="bibr" rid="R41"><sup>41</sup></xref> <xref ref-type="bibr" rid="R42"><sup>42</sup></xref>.</p>
      <p>The overlapping signs and symptoms between MD and
MAV have caused some Authors to suggest the possibility
of a common link in the pathogenesis of the two diseases.</p>
      <p>As the vestibular nuclei receive noradrenergic fibres from
the <italic>locus coeruleus</italic> <xref ref-type="bibr" rid="R43"><sup>43</sup></xref> and serotonergic afference from the dorsal raphe nucleus <xref ref-type="bibr" rid="R44"><sup>44</sup></xref>, it is likely that activation of these
pathways, in migraine, could also activate central vestibular
processing <xref ref-type="bibr" rid="R45"><sup>45</sup></xref>. Moreover, the reciprocal connection of
vestibular nuclei and trigeminal nucleus <italic>caudalis</italic> may provide
a close link between vestibular and vascular-trigeminal
processing during migraine attacks and trigeminal
inner ear sensory innervation may explain the peripheral
neuro-otological disorders. Short duration vertigo may be
related to vasospasm-induced ischaemia of the labyrinth
and repeated episodes may lead to irreversible damage <xref ref-type="bibr" rid="R46"><sup>46</sup></xref>.
Moreover, it has been suggested that endo-lymphatic hydrops
may develop in an ear previously compromised by
vasospasm due to a migrainous mechanism <xref ref-type="bibr" rid="R14"><sup>14</sup></xref>.</p>
      <p>Shepard <xref ref-type="bibr" rid="R17"><sup>17</sup></xref> suggested the following practical criteria in order
to differentiate MD and MAV:</p>
      <list list-type="bullet">
        <list-item>
          <p>The use of a consistent and verifiable definition of MAV is important for consistency and comparison across facilities and clinical trials regarding diagnoses and treatment. MAV must be considered as part of the differential diagnosis.</p>
        </list-item>
        <list-item>
          <p>In the patient's history, the report of only very short (seconds to less than 15 minutes) or prolonged (more than 24 hours) vertigo spells are more likely due to migraine rather than MD. Moreover, if the spontaneous spells of vertigo are associated with migraine features (phono- or photo-phobia), migraine is the probable source.</p>
        </list-item>
        <list-item>
          <p>In MAV, audiometric and vestibular anomalies are more typically mild in magnitude and stable over time rather than fluctuating.</p>
        </list-item>
      </list>
      <p>As a final personal consideration, when symptoms coexist
with migraine, a trial with a migraine management regimen
is suggested. MAV is, above all, a diagnosis of exclusion
based on clinical history <xref ref-type="bibr" rid="R47"><sup>47</sup></xref>. It should be of some
importance, the idea that aggressive drug treatment for
migraine is anyway more mild than aggressive treatment
for MD.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R01">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gordon</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>Meni&#xE8;re&#x2019;s disease</article-title>
          <source>Lancet</source>
          <year>2006</year>
          <volume>367</volume>
          <fpage>984</fpage>
          <lpage>984</lpage>
          <pub-id pub-id-type="pmid">16564356</pub-id>
        </element-citation>
      </ref>
      <ref id="R02">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>James</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Thorp</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Meni&#xE8;re&#x2019;s disease</article-title>
          <source>Clin Evid</source>
          <year>2003</year>
          <volume>116</volume>
          <fpage>565</fpage>
          <lpage>573</lpage>
          <pub-id pub-id-type="pmid">12967379</pub-id>
        </element-citation>
      </ref>
      <ref id="R03">
        <label>3.</label>
        <element-citation publication-type="journal">
          <collab collab-type="authors">Committee on Hearing and Equilibrium</collab>
          <article-title>Guidelines for the
diagnosis and evaluation of therapy in Meni&#xE8;re&#x2019;s disease</article-title>
          <source>Otolaryngol Head Neck Surg</source>
          <year>1995</year>
          <volume>113</volume>
          <fpage>181</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="pmid">7675476</pub-id>
        </element-citation>
      </ref>
      <ref id="R04">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meni&#xE8;re</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Pathologie auriculaire: memoires sur une lesion
de l&#x2019;oreille interne donnant lieu &#xE0; des symptoms de congestion
cerebrale apoplectiforme</article-title>
          <source>Gaz Med Paris</source>
          <year>1861</year>
          <volume>16</volume>
          <fpage>597</fpage>
          <lpage>601</lpage>
        </element-citation>
      </ref>
      <ref id="R05">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rassekh</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Harker</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>The prevalence of migraine in
Meni&#xE8;re&#x2019;s disease</article-title>
          <source>Laryngoscope</source>
          <year>1992</year>
          <volume>102</volume>
          <fpage>135</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">1738284</pub-id>
        </element-citation>
      </ref>
      <ref id="R06">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radtke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lempert</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gresty</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Migraine and
Meni&#xE8;re&#x2019;s disease</article-title>
          <source>Neurology</source>
          <year>2002</year>
          <volume>59</volume>
          <fpage>1700</fpage>
          <lpage>1704</lpage>
          <pub-id pub-id-type="pmid">12473755</pub-id>
        </element-citation>
      </ref>
      <ref id="R07">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kayan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hood</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Neuro-otological manifestations of migraine</article-title>
          <source>Brain</source>
          <year>1984</year>
          <volume>107</volume>
          <fpage>1123</fpage>
          <lpage>1142</lpage>
          <pub-id pub-id-type="pmid">6334543</pub-id>
        </element-citation>
      </ref>
      <ref id="R08">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ibekwe</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Fasunla</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Ibekwe</surname>
              <given-names>PU</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Migraine and
Meni&#xE8;re&#x2019;s disease: two different phenomena with frequently
observed concomitant occurrences</article-title>
          <source>J Natl Med Assoc</source>
          <year>2008</year>
          <volume>100</volume>
          <fpage>334</fpage>
          <lpage>338</lpage>
          <pub-id pub-id-type="pmid">18390027</pub-id>
        </element-citation>
      </ref>
      <ref id="R09">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoon-He</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Baloh</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Familiar clustering of migraine,
episodic vertigo, and Meni&#xE8;re&#x2019;s disease</article-title>
          <source>Otol Neurotol</source>
          <year>2007</year>
          <volume>29</volume>
          <fpage>93</fpage>
          <lpage>96</lpage>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furman</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Marcus</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Balaban</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Migrainous vertigo:
development of a pathogenetic model and structured diagnostic
interview</article-title>
          <source>Curr Opin Neurol</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>5</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">12544852</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dieterich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Episodic vertigo related to migraine
(90 cases): vestibular migraine?</article-title>
          <source>J Neurol</source>
          <year>1999</year>
          <volume>246</volume>
          <fpage>883</fpage>
          <lpage>892</lpage>
          <pub-id pub-id-type="pmid">10552234</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teggi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Colombo</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bernasconi</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Migrainous vertigo:
results of caloric testing and stabilometric findings</article-title>
          <source>Headache</source>
          <year>2009</year>
          <volume>49</volume>
          <fpage>435</fpage>
          <lpage>444</lpage>
          <pub-id pub-id-type="pmid">19220504</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neuhauser</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Leopold</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brevern</surname>
              <given-names>M</given-names>
              <prefix>von</prefix>
            </name>
            <etal/>
          </person-group>
          <article-title>The interrelations
of migraine, vertigo and migrainous vertigo</article-title>
          <source>Neurology</source>
          <year>2001</year>
          <volume>56</volume>
          <fpage>436</fpage>
          <lpage>441</lpage>
          <pub-id pub-id-type="pmid">11222783</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Viirre</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Baloh</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Migraine as a cause of sudden hearing
loss</article-title>
          <source>Headache</source>
          <year>1996</year>
          <volume>36</volume>
          <fpage>24</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="pmid">8666532</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ishiyama</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Can migraine damage the
inner ear?</article-title>
          <source>Arch Neurol</source>
          <year>2000</year>
          <volume>57</volume>
          <fpage>1631</fpage>
          <lpage>1634</lpage>
          <pub-id pub-id-type="pmid">11074796</pub-id>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baloh</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Neurotology of migraine</article-title>
          <source>Headache</source>
          <year>1997</year>
          <volume>37</volume>
          <fpage>615</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="pmid">9439080</pub-id>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shepard</surname>
              <given-names>NT</given-names>
            </name>
          </person-group>
          <article-title>Differentiation of Meni&#xE8;re&#x2019;s disease and migraine-
associated dizziness: a review</article-title>
          <source>J Am Acad Audiol</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>69</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">16640061</pub-id>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dimitri</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Wall</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Oas</surname>
              <given-names>JG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Application of multivariate
statistics to vestibular testing: discriminating between
Meni&#xE8;re&#x2019;s disease and migraine associated dizziness</article-title>
          <source>J Vestibular
Res</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>53</fpage>
          <lpage>65</lpage>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Love</surname>
              <given-names>JT</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Basilar artery migraine presenting as fluctuating
hearing loss and vertigo</article-title>
          <source>Otolaryngology</source>
          <year>1978</year>
          <volume>86</volume>
          <fpage>450</fpage>
          <lpage>458</lpage>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Battista</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Audiometric findings of patients with migraineassociated
dizziness</article-title>
          <source>Otol Neurotol</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>987</fpage>
          <lpage>992</lpage>
          <pub-id pub-id-type="pmid">15547431</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernard</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Stenstrom</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Fluctuating hearing losses in
children can be migraine equivalents</article-title>
          <source>Int J Pediatr Otorhinolaryngol</source>
          <year>1988</year>
          <volume>16</volume>
          <fpage>141</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="pmid">3209361</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cutrer</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Baloh</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Migraine-associated dizziness</article-title>
          <source>Headache</source>
          <year>1992</year>
          <volume>32</volume>
          <fpage>300</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="pmid">1399552</pub-id>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reploeg</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Goebel</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Migraine-associated dizziness: patient
characteristics and management options</article-title>
          <source>Otol Neurotol</source>
          <year>2002</year>
          <volume>23</volume>
          <fpage>364</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="pmid">11981397</pub-id>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mathew</surname>
              <given-names>NT</given-names>
            </name>
          </person-group>
          <article-title>The prophylactic treatment of chronic daily
headache</article-title>
          <source>Headache</source>
          <year>2006</year>
          <volume>46</volume>
          <fpage>1552</fpage>
          <lpage>1564</lpage>
          <pub-id pub-id-type="pmid">17115988</pub-id>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silberstein</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Lipton</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Dodick</surname>
              <given-names>DW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Topiramate
Chronic Migraine Study Group. Efficacy and safety
of topiramate for the treatment of chronic migraine: a randomized,
double-blind, placebo-controlled trial</article-title>
          <source>Headache</source>
          <year>2007</year>
          <volume>47</volume>
          <fpage>170</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">17300356</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silvestrini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bartolini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Coccia</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Topiramate in the
treatment of chronic migraine</article-title>
          <source>Cephalalgia</source>
          <year>2003</year>
          <volume>23</volume>
          <fpage>820</fpage>
          <lpage>824</lpage>
          <pub-id pub-id-type="pmid">14510929</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boyev</surname>
              <given-names>PK</given-names>
            </name>
          </person-group>
          <article-title>Meni&#xE8;re&#x2019;s disease or migraine? The clinical significance of fluctuating hearing loss with vertigo</article-title>
          <source>Arch Otolaryngol
Head Neck Surg</source>
          <year>2005</year>
          <volume>131</volume>
          <fpage>457</fpage>
          <lpage>459</lpage>
          <pub-id pub-id-type="pmid">15897428</pub-id>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ortel</surname>
              <given-names>TL</given-names>
            </name>
          </person-group>
          <article-title>Thrombosis and the antiphospholipid syndrome</article-title>
          <source>Hematology Am Soc Hematol Educ Program</source>
          <year>2005</year>
          <volume>462</volume>
          <fpage>468</fpage>
        </element-citation>
      </ref>
      <ref id="R29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levine</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Branch</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Rauch</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The antiphospholipid syndrome</article-title>
          <source>N Engl J Med</source>
          <year>2002</year>
          <volume>346</volume>
          <fpage>752</fpage>
          <lpage>776</lpage>
          <pub-id pub-id-type="pmid">11882732</pub-id>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mirone</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Altomonte</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Raco</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cerebral blood flow
abnormalities detected by SPECT in Beh&#xE7;et&#x2019;s-syndrome-related
psychiatric disorders</article-title>
          <source>Clin Rheumatol</source>
          <year>1998</year>
          <volume>17</volume>
          <fpage>75</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="pmid">9586687</pub-id>
        </element-citation>
      </ref>
      <ref id="R31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oshima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kikuchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Furui</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Cerebral perfusion impairment
with normal magnetic resonance imaging findings
in a patient with neuro-Behcet&#x2019;s disease</article-title>
          <source>Clin Nucl Med</source>
          <year>2000</year>
          <volume>25</volume>
          <fpage>156</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="pmid">10656663</pub-id>
        </element-citation>
      </ref>
      <ref id="R32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Verrotti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cieri</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pelliccia</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lack of association between
antiphospholipid antibodies and migraine in children</article-title>
          <source>Int J Clin Lab Res</source>
          <year>2000</year>
          <volume>30</volume>
          <fpage>109</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">11043505</pub-id>
        </element-citation>
      </ref>
      <ref id="R33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitsikostas</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Is migraine really comorbid with systemic
lupus erythematosus?</article-title>
          <source>Cephalalgia</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>1013</fpage>
          <lpage>1015</lpage>
          <pub-id pub-id-type="pmid">15566414</pub-id>
        </element-citation>
      </ref>
      <ref id="R34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Appenzeller</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Costallat</surname>
              <given-names>LDL</given-names>
            </name>
          </person-group>
          <article-title>Clinical implications of migraine
in systemic lupus erythematosus: relation to cumulative
organ damage</article-title>
          <source>Cephalalgia</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>1024</fpage>
          <lpage>1030</lpage>
          <pub-id pub-id-type="pmid">15566416</pub-id>
        </element-citation>
      </ref>
      <ref id="R35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isenberg</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Meyrick-Thomas</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Snaith</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A study
of migraine in systemic lupus erythematosus</article-title>
          <source>Ann Rheum
Dis</source>
          <year>1982</year>
          <volume>42</volume>
          <fpage>735</fpage>
          <lpage>741</lpage>
        </element-citation>
      </ref>
      <ref id="R36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weder-Cisneros</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>T&#xE9;llez-Zenteno</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Cardiel</surname>
              <given-names>MH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence and factors associated with headache in
patients with systemic lupus erythematosus</article-title>
          <source>Cephalalgia</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>1031</fpage>
          <lpage>1044</lpage>
          <pub-id pub-id-type="pmid">15566417</pub-id>
        </element-citation>
      </ref>
      <ref id="R37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lessa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Santana</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence and classification
of headache in patients with systemic lupus erythematosus</article-title>
          <source>Clin Rheumatol</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>850</fpage>
          <lpage>853</lpage>
          <pub-id pub-id-type="pmid">16437362</pub-id>
        </element-citation>
      </ref>
      <ref id="R38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glanz</surname>
              <given-names>BI</given-names>
            </name>
            <name>
              <surname>Venkatesan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schur</surname>
              <given-names>PH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence of migraine
in patients with systemic lupus erythematosus</article-title>
          <source>Headache</source>
          <year>2001</year>
          <volume>41</volume>
          <fpage>285</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">11264689</pub-id>
        </element-citation>
      </ref>
      <ref id="R39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scolding</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Joseph</surname>
              <given-names>FG</given-names>
            </name>
          </person-group>
          <article-title>The neuropathology and pathogenesis
of systemic lupus erythematosus</article-title>
          <source>Neuropathol Appl
Neurobiol</source>
          <year>2002</year>
          <volume>28</volume>
          <fpage>173</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="pmid">12060342</pub-id>
        </element-citation>
      </ref>
      <ref id="R40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <collab collab-type="authors">ACR Ad Hoc Committee of Neuropsychiatric Lupus Nomenclature</collab>
          <article-title>The American College of Rheumatology nomenclature
and case definitions for neuropsychiatric lupus syndromes</article-title>
          <source>Arthritis Rheum</source>
          <year>1999</year>
          <volume>42</volume>
          <fpage>599</fpage>
          <lpage>608</lpage>
          <pub-id pub-id-type="pmid">10211873</pub-id>
        </element-citation>
      </ref>
      <ref id="R41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xF6;k&#xE7;ay</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Oder</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Celebisoy</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Headache in primary
Sjogren&#x2019;s syndrome: a prevalence study</article-title>
          <source>Acta Neurol Scand</source>
          <year>2008</year>
          <volume>118</volume>
          <fpage>189</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="pmid">18355394</pub-id>
        </element-citation>
      </ref>
      <ref id="R42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Avci</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kutlay</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Argon</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Subclinical cerebral involvement
in Behcet&#x2019;s disease: a SPECT study</article-title>
          <source>Eur J Neurol</source>
          <year>1998</year>
          <volume>5</volume>
          <fpage>49</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">10210811</pub-id>
        </element-citation>
      </ref>
      <ref id="R43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schuerger</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Balaban</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Organization of coeruleo-vestibular
pathways in rats, rabbits and monkeys</article-title>
          <source>Brain Res</source>
          <year>1999</year>
          <volume>30</volume>
          <fpage>189</fpage>
          <lpage>217</lpage>
        </element-citation>
      </ref>
      <ref id="R44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halberstadt</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Balaban</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Serotonergic and nonserotonergic
neurons in the dorsal raphe nucleus send collateralized
projections to both the vestibular nuclei and the central
amygdaloid nucleus</article-title>
          <source>Neuroscience</source>
          <year>2006</year>
          <volume>140</volume>
          <fpage>1067</fpage>
          <lpage>1077</lpage>
          <pub-id pub-id-type="pmid">16600519</pub-id>
        </element-citation>
      </ref>
      <ref id="R45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furman</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Marcus</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Balaban</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Migrainous vertigo:
development of a pathogenetic model and structured diagnostic
interview</article-title>
          <source>Curr Opin Neurol</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>5</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">12544852</pub-id>
        </element-citation>
      </ref>
      <ref id="R46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buisseret-Delmas</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Compoint</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Delfini</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Organisation
of reciprocal connections between trigeminal and vestibular
nuclei in the rat</article-title>
          <source>J Comp Neurol</source>
          <year>1999</year>
          <volume>409</volume>
          <fpage>153</fpage>
          <lpage>168</lpage>
          <pub-id pub-id-type="pmid">10363717</pub-id>
        </element-citation>
      </ref>
      <ref id="R47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minor</surname>
              <given-names>LB</given-names>
            </name>
          </person-group>
          <article-title>Meni&#xE8;re&#x2019;s disease and migraine</article-title>
          <source>Arch Otolaryngol
Head Neck Surg</source>
          <year>2005</year>
          <volume>131</volume>
          <fpage>460</fpage>
          <lpage>460</lpage>
          <pub-id pub-id-type="pmid">15897429</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
